MIAT Is a Pro-fibrotic Long Non-coding RNA Governing Cardiac Fibrosis in Post-infarct Myocardium

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• RNA Biology

Background:

• Myocardial infarction associated transcript (MIAT) is a long non-coding RNA linked to heart attack risk.
• Cardiac fibrosis is a key pathological process following myocardial infarction, leading to heart dysfunction.

Purpose of the Study:

• To investigate the role of MIAT in regulating cardiac fibrosis.
• To elucidate the molecular mechanisms by which MIAT contributes to myocardial infarction pathogenesis.

Main Methods:

• Utilized a mouse model of myocardial infarction (MI).
• Employed small interfering RNA (siRNA) to knockdown MIAT expression.
• Analyzed cardiac fibrosis, cardiac function, and expression of fibrosis-related genes (miR-24, Furin, TGF-β1).
• Experimented with cultured cardiac fibroblasts treated with serum or angiotensin II.

Main Results:

• MIAT was significantly upregulated in a mouse model of MI, correlating with cardiac interstitial fibrosis.
• MIAT upregulation was associated with decreased miR-24 and increased Furin and TGF-β1.
• Knockdown of MIAT attenuated cardiac fibrosis, improved cardiac function, and normalized fibrosis-related gene expression.
• In vitro, MIAT promoted fibroblast proliferation and collagen accumulation, effects reversed by MIAT knockdown or miR-24 overexpression.

Conclusions:

• MIAT is identified as the first pro-fibrotic long non-coding RNA in the heart.
• MIAT plays a critical role in the pathogenesis of myocardial infarction-induced cardiac fibrosis.
• Targeting MIAT may offer a novel therapeutic strategy for treating cardiac fibrosis and dysfunction post-MI.